Haller, S. T., Yan, Y., Drummond, C. A., Xie, J., Tian, J., Kennedy, D. J., . . . Bagrov, A. Y. (2016). Rapamycin Attenuates Cardiac Fibrosis in Experimental Uremic Cardiomyopathy by Reducing Marinobufagenin Levels and Inhibiting Downstream Pro‐Fibrotic Signaling. J Am Heart Assoc.
Chicago ZitierstilHaller, Steven T., et al. "Rapamycin Attenuates Cardiac Fibrosis in Experimental Uremic Cardiomyopathy By Reducing Marinobufagenin Levels and Inhibiting Downstream Pro‐Fibrotic Signaling." J Am Heart Assoc 2016.
MLA ZitierstilHaller, Steven T., et al. "Rapamycin Attenuates Cardiac Fibrosis in Experimental Uremic Cardiomyopathy By Reducing Marinobufagenin Levels and Inhibiting Downstream Pro‐Fibrotic Signaling." J Am Heart Assoc 2016.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.